Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds.

Date:

September 10, 2024

Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary school, researchers have concluded that a Novo Nordisk obesity drug may be safe and effective for kids as young as 6 years of age.

Source link

OPINION: Debate Day Is Upon Us – What Do the Candidates Want to Accomplish?

Crane being hauled by semi hits overpass on I-75 in Dayton; Right lane remains closed

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds.

Recent posts

Oil prices find a floor after 4-day slide despite disappointing Chinese stimulus

Medicare patients could get emergency treatment at home under new bill

Can Disney, NBC and Amazon make money from their NBA deal? That’s complicated, analysts say.

Merck’s stock drops as mixed outlook offsets earnings beat on Keytruda strength

Gold keeps hitting fresh record highs. Here’s what could lift it closer to $3,000.

Mattel’s stock rallies on news of acquisition offer as Hasbro may enter the fray

Wall Street is going all-in on election betting markets. What you need to know.

‘Absurd’ to think Trump’s policies would be inflationary, says possible Treasury pick

IRS has made ‘limited progress’ figuring out audit rates for those making under $400,000, watchdog says

South Korea’s brief martial-law showdown: What U.S. investors need to know

Harris sees ‘next generation of breakthroughs’ built by U.S. workers. AI, crypto could benefit.

Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

GM and Hyundai to explore cooperating on vehicles, supply chain and clean-energy technology

ADP jobs report shows 143,000 gain. Cooling U.S. labor market leads to slower wage increases.

Federal Reserve proposes more transparency in bank stress tests, but banks still sue

Related articles

Federal Reserve proposes more transparency in bank stress tests, but banks still sue

Oil prices stuck between geopolitical worries and expectations for surplus

Hyatt may add hotels in Mexico, Jamaica with potential Playa merger

Forget the stock-market tumble — the Fed made the right move in a wild week

Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

How this Treasury-market dynamic could lead to the next big leg lower in stocks

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Company

Follow us